Stellar Pharmaceuticals Inc., (TSX VENTURE:SLX)(OTCBB:SLXCF) (“Stellar” or “the Company”), a Canadian pharmaceutical developer and marketer of high quality, cost-effective products for select health care markets, today announced financial results for the fourth quarter and year ended December 31, 2005. All amounts in this press release are in Canadian dollars, and are the result of the use of U.S. GAAP.
